Interpreting global trends in type 2 diabetes complications and mortality

MK Ali, J Pearson-Stuttard, E Selvin, EW Gregg - Diabetologia, 2022 - Springer
International trends in traditional diabetes complications (cardiovascular, renal, peripheral
vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly …

The role of structural racism and geographical inequity in diabetes outcomes

S Agarwal, AN Wade, JC Mbanya, C Yajnik, N Thomas… - The Lancet, 2023 - thelancet.com
Diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …

[HTML][HTML] Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of …

KL Ong, LK Stafford, SA McLaughlin, EJ Boyko… - The Lancet, 2023 - thelancet.com
Background Diabetes is one of the leading causes of death and disability worldwide, and
affects people regardless of country, age group, or sex. Using the most recent evidentiary …

Carotenoids Composition of Green Algae Caulerpa racemosa and Their Antidiabetic, Anti-Obesity, Antioxidant, and Anti-Inflammatory Properties

R Kurniawan, F Nurkolis, NA Taslim, D Subali, R Surya… - Molecules, 2023 - mdpi.com
Green alga Caulerpa racemosa is an underexploited species of macroalgae, even though it
is characterized by a green color that indicates an abundance of bioactive pigments, such as …

The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low-and middle-income countries—a review of the current …

C George, JB Echouffo-Tcheugui, BG Jaar, IG Okpechi… - BMC medicine, 2022 - Springer
Chronic kidney disease (CKD) in people with diabetes is becoming an increasing major
public health concern, disproportionately burdening low-and middle-income countries …

Artificial intelligence for diabetes care: current and future prospects

B Sheng, K Pushpanathan, Z Guan, QH Lim… - The Lancet Diabetes & …, 2024 - thelancet.com
Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise
care for people with diabetes and adapt treatments for complex presentations. However, the …

Achievement of guideline-recommended targets in diabetes care in China: a nationwide cross-sectional study

VW Zhong, D Yu, L Zhao, Y Yang, X Li, Y Li… - Annals of Internal …, 2023 - acpjournals.org
Background: Nationwide achievement of guideline-recommended diabetes care targets has
not been comprehensively assessed in China. Objective: To estimate the proportions of …

Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative …

NE Rahim, D Flood, ME Marcus… - The Lancet Global …, 2023 - thelancet.com
Background The global burden of diabetes is rising rapidly, yet there is little evidence on
individual-level diabetes prevention activities undertaken by health systems in low-income …

Advances in the management of type 2 diabetes in adults

RJ Galindo, JM Trujillo, CCL Wang… - BMJ medicine, 2023 - pmc.ncbi.nlm.nih.gov
Type 2 diabetes is a chronic and progressive cardiometabolic disorder that affects more than
10% of adults worldwide and is a major cause of morbidity, mortality, disability, and high …

Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national …

RM Anjana, R Unnikrishnan, M Deepa… - The Lancet Diabetes & …, 2022 - thelancet.com
Background There is little information on comprehensive diabetes care comprising
glycaemic, lipid, and blood pressure control in India; therefore, we aimed to assess the …